Advertisement
<< Back To Article
PARP Inhibitors as New Standard of Care for More Ovarian Cancers

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

1 Comments

M. Phillips

I am a Braca2+ pt in a clinical trialvtesting this drug for pancreatic ca pt. I am on my 32 cycle of this trial. I am doing well. There is some hope shown here.

February 19, 2019 Virginia

Advertisement

Hot topics